LFCR LIFECORE BIOMEDICAL, INC. \DE\: institutional ownership and insider trading
107 funds reported holding $148M of LIFECORE BIOMEDICAL, INC. \DE\ in their latest 13F filings; in Q2 2026 funds net bought $1.60M, with 14 new positions and 18 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Famous investors holding LFCR
- Izzy Englander (Millennium Management): $700K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $551K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $519K, 0.0% of the portfolio
Largest institutional holders of LFCR
- WYNNEFIELD CAPITAL INC — $24.7M
- Legion Partners Asset Management, LLC — $23.4M
- Greenhaven Road Investment Management, L.P. — $16.8M
- 325 CAPITAL LLC — $15.2M
- VANGUARD GROUP INC — $13.7M
- BlackRock, Inc. (BLK) — $10.6M
- VANGUARD CAPITAL MANAGEMENT LLC — $6.77M
- GEODE CAPITAL MANAGEMENT, LLC — $4.49M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $4.04M
- STATE STREET CORP (STT, STT-PG) — $3.51M
Recent LFCR insider trades
- May 28, 2025: 22NW Fund, LP sold 1,386,060 shares ($9.13M)
- May 13, 2025: 22NW Fund, LP sold 12,334 shares ($86.3K)
- May 12, 2025: 22NW Fund, LP sold 51,496 shares ($362K)
- May 7, 2025: 22NW Fund, LP sold 41,091 shares ($290K)
5%+ owners
- Legion Partners Holdings, LLC: 17.3% (Schedule 13D/A, filed Sep 28, 2026)
- Nelson Obus: 14.3% (Schedule 13D/A, filed Sep 29, 2026)
- 22NW Fund, LP: 6.7% (Schedule 13D/A, filed Jul 2, 2026)
- BlackRock, Inc.: 5.4% (Schedule 13G, filed Jul 29, 2026)